APA (7th ed.) Citation

CS, H., KA, S., A, M., S, K., J, C., J, D., . . . CC, D. (2022). A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients. Pediatric blood & cancer, 69(5), e29641. https://doi.org/10.1002/pbc.29641

Chicago Style (17th ed.) Citation

CS, Higham, et al. "A Pilot Trial of Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-risk Pediatric Patients." Pediatric Blood & Cancer 69, no. 5 (2022): e29641. https://doi.org/10.1002/pbc.29641.

MLA (9th ed.) Citation

CS, Higham, et al. "A Pilot Trial of Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-risk Pediatric Patients." Pediatric Blood & Cancer, vol. 69, no. 5, 2022, p. e29641, https://doi.org/10.1002/pbc.29641.